HighMark Wealth Management’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RXRX
HighMark Wealth Management's RXRX Position: Q3 2026 in Review
HighMark Wealth Management opened a new position in Recursion Pharmaceuticals (RXRX) in Q3 2026: 53 shares worth $218. The stake represents ﹤0.01% of the portfolio and ranks #549 among its holdings.
352 funds tracked by Wall St. Rank hold RXRX as of Q3 2026.
- HighMark Wealth Management held 53 shares of Recursion Pharmaceuticals worth $218 as of Q3 2026.
- Recursion Pharmaceuticals was a new HighMark Wealth Management position in Q3 2026.
- Recursion Pharmaceuticals made up ﹤0.01% of HighMark Wealth Management's portfolio in Q3 2026, its #549 holding.
- 352 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q3 2026.
Based on HighMark Wealth Management's 13F filing for Q3 2026, filed 17 Nov 2026.